Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Omrix Biopharmaceuticals, Inc. (OMRI)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: OMRI
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
IPO Analysis: Talecris Biotherapeutics Is Positioned Well in the U.S. Plasma Market
Bill Simpson
•
Oct 02
•
Comment!
A Comparison of M&A Activity During Bull and Bear markets
Dr. Kris
•
Jan 30
•
2 Comments
Israeli M&A Market Heats Up as St. Jude Medical Acquires MediGuide
Aaron Katsman
•
Dec 24
•
Comment!
40 Top Rated Emerging Bio-Pharma Stocks
Mike Havrilla
•
Dec 23
•
Comment!
Nine Pharma Predictions for 2009
Mike Huckman
•
Dec 02
•
2 Comments
Wall Street Breakfast: Must-Know News
SA Editor Rachael Granby
•
Nov 25
•
9 Comments
More articles on OMRI »
Latest Transcript
Omrix Biopharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
Mon November 24, 2008
More transcripts on OMRI »
Sentiment
What advice would you give to
OMRI?
123 characters left
What's your view of OMRI?
Make sure you include OMRI
140 characters left
|
Settings